Literature DB >> 3892018

The 1.8 A structure of the complex between chymostatin and Streptomyces griseus protease A. A model for serine protease catalytic tetrahedral intermediates.

L T Delbaere, G D Brayer.   

Abstract

The naturally occurring serine protease inhibitor, chymostatin, forms a hemiacetal adduct with the catalytic Ser195 residue of Streptomyces griseus protease A. Restrained parameter least-squares refinement of this complex to 1.8 A resolution has produced an R index of 0 X 123 for the 11,755 observed reflections. The refined distance of the carbonyl carbon atom of the aldehyde to O gamma of Ser195 is 1 X 62 A. Both the R and S configurations of the hemiacetal occur in equal populations, with the end result resembling the expected configuration for a covalent tetrahedral product intermediate of a true substrate. This study strengthens the concept that serine proteases stabilize a covalent, tetrahedrally co-ordinated species and elaborates those features of the enzyme responsible for this effect. We propose that a major driving force for the hydrolysis of peptide bonds by serine proteases is the non-planar distortion of the scissile bond by the enzyme, which thereby lowers the activation energy barrier to hydrolysis by eliminating the resonance stabilization energy of the peptide bond.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3892018     DOI: 10.1016/0022-2836(85)90283-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.

Authors:  G Barbato; D O Cicero; F Cordier; F Narjes; B Gerlach; S Sambucini; S Grzesiek; V G Matassa; R De Francesco; R Bazzo
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  A fast unbiased comparison of protein structures by means of the Needleman-Wunsch algorithm.

Authors:  J Rose; F Eisenmenger
Journal:  J Mol Evol       Date:  1991-04       Impact factor: 2.395

3.  Two crystal structures of the leupeptin-trypsin complex.

Authors:  I V Kurinov; R W Harrison
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

4.  A 13C-NMR study of the role of Asn-155 in stabilizing the oxyanion of a subtilisin tetrahedral adduct.

Authors:  T P O'connell; R M Day; E V Torchilin; W W Bachovchin; J G Malthouse
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

5.  Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131.

Authors:  Gabriel Birkus; Ruth Wang; Xiaohong Liu; Nilima Kutty; Holly MacArthur; Tomas Cihlar; Craig Gibbs; Swami Swaminathan; William Lee; Martin McDermott
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

6.  The probable conformation of substrates recognized by dipeptidyl-peptidase IV and some aspects of the catalytic mechanism derived from theoretical investigations.

Authors:  W Brandt; T Lehmann; T Hofmann; R L Schowen; A Barth
Journal:  J Comput Aided Mol Des       Date:  1992-04       Impact factor: 3.686

7.  Synthetic analogues of chymostatin. Inhibition of chymotrypsin and Streptomyces griseus proteinase A.

Authors:  N P Tomkinson; I J Galpin; R J Beynon
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

8.  Peptide glyoxals: a novel class of inhibitor for serine and cysteine proteinases.

Authors:  B Walker; N McCarthy; A Healy; T Ye; M A McKervey
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

9.  Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.

Authors:  Lili Zhu; Shyla George; Marco F Schmidt; Samer I Al-Gharabli; Jörg Rademann; Rolf Hilgenfeld
Journal:  Antiviral Res       Date:  2011-08-11       Impact factor: 5.970

10.  Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin.

Authors:  Jennifer A Cleary; William Doherty; Paul Evans; J Paul G Malthouse
Journal:  Biochim Biophys Acta       Date:  2014-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.